A head-to-head observational cohort study on the efficacy and safety of monoclonal antibodies against calcitonin gene-related peptide for chronic and episodic migraine.

Francesco Saccà,Simone Braca,Mattia Sansone,Angelo Miele,Antonio Stornaiuolo,Roberto De Simone,Cinzia Valeria Russo

Headache（2023）

引用 0|浏览4

暂无评分

摘要

Our results confirm the therapeutic benefits of anti-CGRP mAbs. There is no evidence that suggests that one antibody may be superior to the others in terms of effectiveness, both in chronic and episodic patients.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要